Cronos Group - Common Share (CRON) closed at $3.27 on November 16, 2026, down 3.3% from the previous close, on volume of 888,855 shares (30-day average 991,340).
Data as of November 16, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Ratio Call Spread 1 by 2 | 21-Jan-283.5 : 5[2x] C | 6,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 16, 2026. See the largest for 5, 30, 60 and 90 days
Business Wire (Tue, 17-Nov 7:30 AM ET)
Cronos Group Reports 2026 Third Quarter Results
Globe Newswire (Thu, 5-Nov 7:30 AM ET)
Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company
Globe Newswire (Thu, 15-Oct 7:00 AM ET)
Globe Newswire (Tue, 13-Oct 7:30 AM ET)
Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026
Globe Newswire (Thu, 8-Oct 7:30 AM ET)
Cronos Hosts 2026 Investor Day
Globe Newswire (Thu, 24-Sep 8:00 AM ET)
Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
Globe Newswire (Tue, 15-Sep 4:15 PM ET)
Cronos' brand Spinach Expands its Best-Selling Lineups of Edibles and Vapes
Globe Newswire (Wed, 2-Sep 7:30 AM ET)
Market Chameleon (Thu, 6-Aug 6:38 AM ET)
Market Chameleon (Mon, 11-May 6:34 AM ET)
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
Cronos Group - Common Share trades on the NASDAQ stock market under the symbol CRON.
As of November 17, 2026, CRON stock price declined to $3.21 with 400,312 million shares trading.
CRON has a beta of 0.01, meaning it tends to be less sensitive to market movements. CRON has a correlation of 0.00 to the broad based SPY ETF.
CRON has a market cap of $1.18 billion. This is considered a Small Cap stock.
Last quarter Cronos Group - Common Share reported $63 million in Revenue and $.04 earnings per share. This fell short of revenue expectation by $-5 million and met earnings estimates .
In the last 3 years, CRON traded as high as $3.91 and as low as $1.60.
The top ETF exchange traded funds that CRON belongs to (by Net Assets): DFIS, DFIC, ONEQ, DFAX, GWX.
CRON has outperformed the market in the last year with a return of +31.0%, while the SPY ETF gained +10.1%. In the last 3 month period, CRON beat the market returning +2.2%, while SPY returned -5.4%. However, in the most recent 2 weeks CRON has underperformed the stock market by returning -3.6%, while SPY returned -2.6%.
CRON support price is $3.20 and resistance is $3.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRON shares will trade within this expected range on the day.